{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:15:25Z","timestamp":1775711725013,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12098-020-03565-9","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T06:13:55Z","timestamp":1609827235000},"page":"764-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy"],"prefix":"10.1007","volume":"88","author":[{"given":"P. B.","family":"Nandith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Adiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijaya","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachidananda","family":"Adiga M N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"3565_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"R Fisher","year":"2014","unstructured":"Fisher R. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475\u201382.","journal-title":"Epilepsia"},{"key":"3565_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4103\/0972-2327.160093","volume":"18","author":"S Amudhan","year":"2015","unstructured":"Amudhan S, Gururaj G, Satishchandra P. Epilepsy in India I: epidemiology and public health. Ann Indian Acad Neurol. 2015;18:263\u201377.","journal-title":"Ann Indian Acad Neurol"},{"key":"3565_CR3","doi-asserted-by":"crossref","unstructured":"Jain P, Shastri S, Gulati S, et al. Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy. Neurol India. 2015;63:35\u20139.","DOI":"10.4103\/0028-3886.152631"},{"key":"3565_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.2217\/pgs.12.78","volume":"13","author":"D Chatzistefanidis","year":"2012","unstructured":"Chatzistefanidis D, Georgiou I, Kyritsis AP, Markoula S. Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid. Pharmacogenomics. 2012;13:1055\u201371.","journal-title":"Pharmacogenomics."},{"key":"3565_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00008571-199712000-00007","volume":"7","author":"M Ciotti","year":"1997","unstructured":"Ciotti M, Marrone A, Potter C, Owens IS. Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyl transferase: pharmacological implications. Pharmacogenetics. 1997;7:485\u201395.","journal-title":"Pharmacogenetics."},{"key":"3565_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0168-8278(02)00306-9","volume":"38","author":"WHM Peters","year":"2003","unstructured":"Peters WHM, te Morsche RHM, Roelofs HMJ. Combined polymorphisms in UDP-glucuronosyl transferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. J Hepatol. 2003;38:3\u20138.","journal-title":"J Hepatol"},{"key":"3565_CR7","unstructured":"Ma H, Zhang T, Gong Z, et al. Effect of UGT2B7 genetic variants on serum valproic acid concentration. J Central South Univ Med Sci. 2013;38:766\u201372."},{"key":"3565_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/FTD.0000000000000012","volume":"36","author":"K Inoue","year":"2014","unstructured":"Inoue K, Suzuki BS, Yazawa R, et al. Influence of uridine diphosphate glucuronosyl transferase 2B7-161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients. Ther Drug Monit. 2014;36:406\u20139.","journal-title":"Ther Drug Monit"},{"key":"3565_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40291-013-0041-8","volume":"17","author":"M Munisamy","year":"2013","unstructured":"Munisamy M, Tripathy M, Behari M, et al. The effect of uridine disphosphate glucuronosyltransferase (UGT) 1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach. Mol Diagn Ther. 2013;17:319\u201326.","journal-title":"Mol Diagn Ther"},{"key":"3565_CR10","doi-asserted-by":"crossref","unstructured":"Hung CC, Ho JL, Chang WL, et al. Association of genetic variants in six candidate genes with valproic acid therapy optimization. Pharmacogenomics. 2011;12:1107\u201317.","DOI":"10.2217\/pgs.11.64"},{"key":"3565_CR11","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00228-012-1277-7","volume":"68","author":"XM Chu","year":"2012","unstructured":"Chu XM, Zhang LF, Wang GJ, Zhang SN, Zhou JH, Hao HP. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. Eur J Clin Pharmacol. 2012;68:1395\u2013401.","journal-title":"Eur J Clin Pharmacol"},{"key":"3565_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","volume":"27","author":"Y Guo","year":"2012","unstructured":"Guo Y, Hu C, He X, Qiu F, Zhao L. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Drug Metab Pharmacokinet. 2012;27:536\u201342.","journal-title":"Drug Metab Pharmacokinet"},{"key":"3565_CR13","doi-asserted-by":"crossref","unstructured":"Xing Y, Yang L, Wang L, et al. Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling. Pharmacogenomics. 2009;10:741\u201352.","DOI":"10.2217\/pgs.09.21"},{"key":"3565_CR14","doi-asserted-by":"crossref","unstructured":"Saeki M, Saito Y, Jinno H, et al. Genetic polymorphisms of UGT1A6 in a Japanese population. Drug Metab Pharmacokinet. 2005;20:85\u201390.","DOI":"10.2133\/dmpk.20.85"},{"key":"3565_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00008571-199906000-00009","volume":"9","author":"JW Lampe","year":"1999","unstructured":"Lampe JW, Bigler J, Horner NK, Potter JD. UDP-glucuronosyl transferase (UGT1A1 * 28 and UGT1A6 * 2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenet. 1999;9:341\u20139.","journal-title":"Pharmacogenet."},{"key":"3565_CR16","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.12659\/MSM.897626","volume":"22","author":"D Zhongliang","year":"2016","unstructured":"Zhongliang D, Jiao Y, Shi L. Association of UGT2B7 and UGT1A4 polymorphisms with serum concentration of antiepileptic drugs in children. Med Sci Monit. 2016;22:4107\u201313.","journal-title":"Med Sci Monit"},{"key":"3565_CR17","doi-asserted-by":"crossref","unstructured":"Sun YX, Zhuo WY, Lin H, et al. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients. Epilepsy Res. 2015;114:78\u201380.","DOI":"10.1016\/j.eplepsyres.2015.04.015"},{"key":"3565_CR18","first-page":"429","volume":"12","author":"Y Wang","year":"2010","unstructured":"Wang Y, Gao L, Liu YP, Huang NN, Xu SJ, Ma DJ. Effect of UGTIA6 A541G genetic polymorphism on the metabolism of valproic acid in Han epileptic children from Henan. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12:429\u201332.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-020-03565-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T08:33:23Z","timestamp":1627029203000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-020-03565-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3565"],"URL":"https:\/\/doi.org\/10.1007\/s12098-020-03565-9","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}